Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nobuko Hijiya

Showing results (51-60 of 85) with videos related to

Pageof 9
Sort By:
Blood|February 1, 2007
Ancestry and pharmacogenetics of antileukemic drug toxicityShinji Kishi, Cheng Cheng, Deborah French, et al.
Pediatric Blood & Cancer|May 17, 2023
Child and family perceptions of satisfaction with neutropenia management in pediatric acute myeloid leukemiaJulia E Szymczak, Kelly D Getz, Rachel Madding, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 3, 2019
Pharmacokinetics of Nilotinib in Pediatric Patients with Philadelphia Chromosome-Positive Chronic Myeloid Leukemia or Acute Lymphoblastic LeukemiaNobuko Hijiya, C Michel Zwaan, Carmelo Rizzari, et al.
Blood|August 19, 2006
Body mass index does not influence pharmacokinetics or outcome of treatment in children with acute lymphoblastic leukemiaNobuko Hijiya, John C Panetta, Yinmei Zhou, et al.
Pediatric Blood & Cancer|September 17, 2015
Activity and Toxicity of Intravenous Erwinia Asparaginase Following Allergy to E. coli-Derived Asparaginase in Children and Adolescents With Acute Lymphoblastic LeukemiaLynda M Vrooman, Ivan I Kirov, ZoAnn E Dreyer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2005
Risk of adverse events after completion of therapy for childhood acute lymphoblastic leukemiaChing-Hon Pui, Deqing Pei, John T Sandlund, et al.
JAMA|March 22, 2007
Cumulative incidence of secondary neoplasms as a first event after childhood acute lymphoblastic leukemiaNobuko Hijiya, Melissa M Hudson, Shelly Lensing, et al.
Cancer|June 4, 2016
Patterns and predictors of clustered risky health behaviors among adult survivors of childhood cancer: A report from the Childhood Cancer Survivor StudyE Anne Lown, Nobuko Hijiya, Nan Zhang, et al.
British Journal of Haematology|January 25, 2020
Experience with ponatinib in paediatric patients with leukaemiaJenna Rossoff, Van Huynh, Rachel E Rau, et al.
Blood|October 5, 2011
Phase 2 trial of clofarabine in combination with etoposide and cyclophosphamide in pediatric patients with refractory or relapsed acute lymphoblastic leukemiaNobuko Hijiya, Blythe Thomson, Michael S Isakoff, et al.
Pageof 9

Showing results (51-60 of 85) with videos related to

Sort By:
Pageof 9
Blood|February 1, 2007
Ancestry and pharmacogenetics of antileukemic drug toxicityShinji Kishi, Cheng Cheng, Deborah French, et al.
Pediatric Blood & Cancer|May 17, 2023
Child and family perceptions of satisfaction with neutropenia management in pediatric acute myeloid leukemiaJulia E Szymczak, Kelly D Getz, Rachel Madding, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 3, 2019
Pharmacokinetics of Nilotinib in Pediatric Patients with Philadelphia Chromosome-Positive Chronic Myeloid Leukemia or Acute Lymphoblastic LeukemiaNobuko Hijiya, C Michel Zwaan, Carmelo Rizzari, et al.
Blood|August 19, 2006
Body mass index does not influence pharmacokinetics or outcome of treatment in children with acute lymphoblastic leukemiaNobuko Hijiya, John C Panetta, Yinmei Zhou, et al.
Pediatric Blood & Cancer|September 17, 2015
Activity and Toxicity of Intravenous Erwinia Asparaginase Following Allergy to E. coli-Derived Asparaginase in Children and Adolescents With Acute Lymphoblastic LeukemiaLynda M Vrooman, Ivan I Kirov, ZoAnn E Dreyer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2005
Risk of adverse events after completion of therapy for childhood acute lymphoblastic leukemiaChing-Hon Pui, Deqing Pei, John T Sandlund, et al.
JAMA|March 22, 2007
Cumulative incidence of secondary neoplasms as a first event after childhood acute lymphoblastic leukemiaNobuko Hijiya, Melissa M Hudson, Shelly Lensing, et al.
Cancer|June 4, 2016
Patterns and predictors of clustered risky health behaviors among adult survivors of childhood cancer: A report from the Childhood Cancer Survivor StudyE Anne Lown, Nobuko Hijiya, Nan Zhang, et al.
British Journal of Haematology|January 25, 2020
Experience with ponatinib in paediatric patients with leukaemiaJenna Rossoff, Van Huynh, Rachel E Rau, et al.
Blood|October 5, 2011
Phase 2 trial of clofarabine in combination with etoposide and cyclophosphamide in pediatric patients with refractory or relapsed acute lymphoblastic leukemiaNobuko Hijiya, Blythe Thomson, Michael S Isakoff, et al.
Pageof 9